| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |